Theravance Biopharma, Inc. (TBPH)
17.01
-0.01
(-0.06%)
USD |
NASDAQ |
May 08, 16:00
17.03
+0.02
(+0.12%)
After-Hours: 20:00
Theravance Biopharma EPS Diluted (Quarterly) : -0.0962 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Viatris, Inc. | 0.1501 |
| Relmada Therapeutics, Inc. | -0.2911 |
| Indivior Pharmaceuticals, Inc. | 0.6899 |
| Corcept Therapeutics, Inc. | -0.2988 |
| Assertio Holdings, Inc. | -2.931 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.933M |
| Revenue (Quarterly) | 17.70M |
| Total Expenses (Quarterly) | 22.63M |
| Enterprise Value | 555.55M |
| Gross Profit Margin (Quarterly) | 91.88% |
| Profit Margin (Quarterly) | -27.87% |
| Earnings Yield | 12.96% |
| Operating Earnings Yield | 0.01% |
| Normalized Earnings Yield | 13.25 |